Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
38198
CAS Number:
257933-82-7
Pelitinib
Purity:
≥ 97% (HPLC)
Synonym(s):
EKB 569, (2E-N-[4-[(3-Chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-dimethylamino-2-butenamide
Hazmat
Documents
$261.99 /25MG
Pack Size Availability Price
Request Bulk Quote
Product Information
Synonyms
EKB 569, (2E-N-[4-[(3-Chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-dimethylamino-2-butenamide
CAS Number
257933-82-7
Purity
≥ 97% (HPLC)
Molecular Formula
C24H23ClFN5O2
Molecular Weight
0
MDL Number
MFCD09837868
PubChem ID
216467
Melting Point
197 - 199 °C
Appearance
White to light yellow powder to crystal
Conditions
Store at < 0 °C
General Information
Synonyms
EKB 569, (2E-N-[4-[(3-Chloro-4-fluorophenyl)amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-dimethylamino-2-butenamide
CAS Number
257933-82-7
Purity
≥ 97% (HPLC)
Molecular Formula
C24H23ClFN5O2
Molecular Weight
0
MDL Number
MFCD09837868
PubChem ID
216467
Melting Point
197 - 199 °C
Appearance
White to light yellow powder to crystal
Conditions
Store at < 0 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
Yes
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

Pelitinib is widely utilized in research focused on:

  • Cancer Treatment: Pelitinib is primarily studied for its potential in treating various types of cancer, particularly non-small cell lung cancer (NSCLC). Its targeted action on specific cancer cell pathways makes it a promising candidate for personalized medicine.
  • Drug Development: Researchers are exploring Pelitinib as a lead compound for developing new anti-cancer drugs. Its unique structure allows for modifications that can enhance efficacy and reduce side effects compared to traditional chemotherapy agents.
  • Combination Therapies: Pelitinib is being investigated in combination with other therapies to improve treatment outcomes. This approach can help overcome resistance mechanisms that often limit the effectiveness of single-agent treatments.
  • Biomarker Research: The use of Pelitinib in clinical studies is aiding the identification of biomarkers that predict patient responses to treatment, which is crucial for optimizing therapy and improving patient outcomes.
  • Pharmacokinetic Studies: Pelitinib's pharmacokinetic profile is being analyzed to understand its absorption, distribution, metabolism, and excretion in the body, providing valuable information for dosage optimization and safety assessments.

Citations